Production at Brampton Manufacturing Hub to
commence immediately
TORONTO, Nov. 18, 2019 /CNW/ - Pure Global Cannabis Inc.
(TSX.V:PURE; OTC: PRCNF) (the "Company" or "Pure
Global" or "Pure"), an integrated growth-oriented
cannabis bulk extracts and consumer products manufacturing company,
operating through its wholly-owned subsidiary PureSinse Inc., a
Health Canada Licensed Producer under the Cannabis Act, is very
pleased to announce that it has received approvals from Health
Canada to amend its existing license to add manufacturing
capabilities via phase 2 of its already licensed facility in
Brampton. Having completed their
facility in the spring, the Company can begin cultivation and
extraction immediately now that all approvals have been granted.
This is a transformational event for the Company as it enables its
own production as opposed to previously being dependent on
wholesale purchases for its inventory hence significantly expanding
its sales and margin potential.
Pure Global's facility was designed and built to exceed
regulatory standards. This approval enables the addition of a
10,000 square foot EU-GMP grade manufacturing space, comprising 12
rooms that will be used for cultivation, processing, and
extraction, to the Company's already licensed site.
With these Health Canada approvals, The Company can
immediately:
- commence using its 6 tons CO2 extraction system towards
enabling bulk cannabis extract and distillate sales
- commence multi-layer and vertical cultivation towards 50-100 kg
per month capacity, with the first harvest expected in Q1 2020
- commence final testing of proprietary vertical growing system
for phase 3 scaled deployment
- continue installation of targeted 100+ tons of biomass
extraction systems for CBD isolate manufacturing for Q1 2020
readiness
- continue installation of scaled processing and packaging for
vape pens, topicals, dried flower, oils, tinctures, and edibles, to
add to the current capacity already in place.
Pure Global aims to become a leader in bulk cannabinoid and
infused product manufacturing in Canada and globally. With the high margins
this sector is experiencing, the Company is well positioned to take
advantage of the growing demand. Along with leveraging its advanced
manufacturing capabilities for white or private label services, the
Company is also introducing its own branded products in targeted
legal adult and health & beauty consumer segments including
PureSinse® Wellness, Paper&Weed Pre-rolls, Kumo Edibles, Galaxy
Premium Cannabis, and The Great Canadian Hemp Co®.
Receiving these cultivation and processing approvals enables the
Company to begin bulk distillate sales and offering
co-manufacturing services through its recently launched B2B brand,
PureCanna Solutions. The Company is currently installing large
scale biomass extraction equipment, with CO2 extraction
capabilities already in place. PureCanna is poised to begin the
sales of bulk concentrates, branded and white-label medical,
recreational and wellness products as well as co-manufacturing and
tolling services almost immediately.
Pure Global CEO & President, Malay Panchal said, "Receiving
our phase 2 approvals from Health Canada is a significant
achievement as it enables us to commence our own cultivation and
extraction for our branded and B2B sales. We have worked tirelessly
to prepare our team, facility, set up distribution channels, and
scale our partnerships in Canada
and globally for this moment. We are building to become a truly
global leader and have positioned ourselves to make huge strides in
the coming quarters. These efforts will help us create significant
value for our shareholders, and we are very excited to be able to
significantly enhance our revenue and margin generating potential
with this approval."
About Pure Global Cannabis
Pure Global is an EU-GMP grade cannabis manufacturer focused on
producing high-quality high margin branded and white label cannabis
and CBD consumer products, premium quality bulk dried flower, full
spectrum concentrates, and pre-formulated active ingredients for
CPG manufacturers globally. The Company is led by a professional
team of experienced pharma, biotechnology, horticultural,
extraction, manufacturing and consumer packaged goods experts, and
operates through its wholly owned subsidiary, PureSinse Inc., which
is a licensed producer under the Cannabis Act. Pure operates a B2B
brand under PureCanna Solutions which is focused on high-margin
bulk cannabis extracts, bulk CBD sales, as well as white label, and
co-manufacturing services. The Company's 18,000 square foot
Brampton manufacturing campus
houses facilities for vertically farmed hydroponic indoor
cultivation, R&D, extraction, processing, and packaging. To
compete in international markets, Pure Global is the process of
deploying a joint operation in Yunnan,
China for large scale hemp derived organic bulk CBD
manufacturing and processing for international bulk and finished
product sale under Special Economic Zone tax-free export
provisions. Pure has also launched, or is in the process of
launching, several premium branded products in targeted consumer
categories into the Canadian legal adult market including
PureSinse® Wellness, Paper&Weed Pre-Rolls, Galaxy Cannabis,
Kumo Edibles, and PureSinse® Medical, which operates with Pure's
wholly own subsidiary Spark Cannabis Clinic, offering free
telemedicine consultation for medical cannabis patients across
Canada. Through its recently
acquired division, The Great Canadian Health Company®, which won
Hemp Product Company of the year at the recent 2019 GrowUp Awards,
Pure is launching a line of organic hemp oil and CBD topical
products, into several markets in Europe and Asia in early 2020.
FORWARD-LOOKING STATEMENTS
This news release contains certain forward-looking statements,
including, but not limited to, statements about Pure Global's
future plans and intentions. Wherever possible, words such as
"may", "will", "should", "could", "expect", "plan", "intend",
"anticipate", "believe", "estimate", "predict" or "potential" or
the negative or other variations of these words, or similar words
or phrases, have been used to identify these forward-looking
statements. These statements reflect management's current beliefs
and are based on information currently available to management as
at the date hereof.
Forward-looking statements involve significant risk,
uncertainties and assumptions. Many factors could cause actual
results, performance or achievements to differ materially from the
results discussed or implied in the forward-looking statements.
These factors should be considered carefully, and readers should
not place undue reliance on the forward-looking statements.
Although the forward-looking statements contained in this news
release are based upon what management believes to be reasonable
assumptions, Pure Global cannot assure readers that actual results
will be consistent with these forward-looking statements. These
forward-looking statements are made as of the date of this news
release, and Pure Global assumes no obligation to update or revise
them to reflect new events or circumstances, except as required by
law.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSXV)
accepts responsibility for the adequacy or accuracy of this
release.
To register to Pure Global's mailing list, please visit
www.pureglobal.com. Follow @pureglobalcanna on Twitter and Facebook
and @pureglobalcannabis on Instagram.
SOURCE Pure Global Cannabis Inc.
